Since the start of May interest in the stock of Arno Therapeutics Inc (OTCMKTS:ARNI) has reached record levels. On April 30 they announced that the European Commission had designated the company’s AR-12 drug as...
The last few sessions have marked a serious volume buildup and price action for Arno Therapeutics, Inc. (OTCMKTS:ARNI). After Friday’s closing bell, ARNI had climbed 70% within the space of four sessions. In its...
After a month of very slow trading and nearly ten days with zero share volume, on Wednesday Arno Therapeutics, Inc. (OTCMKTS:ARNI) suddenly shifted 450 thousand shares. As a result, the company’s share price dropped...